A focused international meeting connecting the clinical, scientific, regulatory, manufacturing, technology and commercial capabilities needed to move phage therapy forward globally.
Phage therapy is advancing rapidly, but progress remains fragmented across countries, healthcare systems, regulatory environments, and commercial ecosystems. Europe, the UK, North America, and the Asia-Pacific region each bring different strengths: clinical experience, scientific expertise, manufacturing capabilities, regulatory knowledge, technology platforms, and access to distinct healthcare and innovation networks.
PrecisionPhage’s Global Phage Therapy Bridge was created to connect these capabilities.
The meeting brings together phage companies, clinicians, researchers, hospitals, manufacturers, technology providers, regulatory experts, investors, and other stakeholders from across the world.
The aim is not to exchange scientific results, although it is of course allowed, but to identify practical opportunities for collaboration. By bringing complementary expertise into the same room, the meeting seeks to support new clinical partnerships, technology and service collaborations, manufacturing and quality solutions, regional market entry, and joint initiatives that can help move phage therapy closer to routine clinical use.
Singapore provides a natural meeting point between East and West: an internationally connected biomedical hub with strong research, healthcare, technology, and business ecosystems. The Global Phage Therapy Bridge is intended to create new connections across these ecosystems and help build a more coordinated, international path for the development and implementation of phage therapy.
Global Phage Therapy Bridge will take place on 27–28 January 2027 at Fairmont Singapore, in the heart of the city.
Fairmont Singapore provides an excellent setting for a meeting built around interaction, networking, and international collaboration. Located at Raffles City, the hotel is directly connected to Singapore’s City Hall and Esplanade MRT stations and within easy reach of Marina Bay, the Civic District, and many of the city’s main attractions.
The venue combines high-quality conference facilities with accommodation, meeting spaces, restaurants, and networking opportunities in one central location. Marina Bay, Gardens by the Bay, the historic Civic District, shopping, restaurants, and many of Singapore’s best-known sights are within convenient reach.
80 Bras Basah Road, Singapore 189560
Visit Fairmont Singapore ↗On the evening of 27 January, participants are invited to continue the discussions from the first conference day over dinner at LeVeL33, located on the 33rd floor of Marina Bay Financial Centre Tower 1.
Overlooking Marina Bay and Singapore’s skyline, LeVeL33 offers a distinctive setting for an informal conference evening, with panoramic views and an on-site craft brewery.
8 Marina Boulevard, #33-01 Marina Bay Financial Centre Tower 1, Singapore 018981
Visit LeVeL33 ↗Six focused sessions across two days, combining practical clinical experience, enabling solutions, regulation, manufacturing, reimbursement and concrete collaboration opportunities.
At Fairmont Singapore.
Clinical teams and hospitals share actual experiences of treating patients with bacteriophages, including patient selection, phage sourcing, outcomes, practical challenges and lessons learned.
A showcase of technologies, services, products and infrastructure intended to help phage therapy move forward globally.
Different national approaches, compassionate and special access pathways, clinical trials, personalised treatments and the potential for greater international regulatory alignment.
Bio- and Medtech Incubator in Singapore, Novena, for easy entry to Singapore for companies.
What level of manufacturing control is truly necessary for therapeutic phages? The discussion considers conventional pharmaceutical GMP and proportionate, risk based approaches.
Reimbursement models, healthcare economics, pricing of personalised therapies, responsibility for diagnostic and manufacturing costs, and evidence of value.
An interactive closing session identifying opportunities for joint projects, clinical collaborations, technology partnerships, regional programmes and shared infrastructure.
The Global Phage Therapy Bridge is designed for organisations and individuals who are actively involved in, or can contribute to, the development and implementation of phage therapy.
The meeting is intended to connect complementary expertise from different regions and to encourage practical collaborations that can help move phage therapy toward broader clinical use.
Access to both conference days, conference catering and the LeVeL33 conference dinner on 27 January.
Per participant
Per participant
A simple visibility package for companies that want to support the meeting and be visible to its international participant group.
Current supporting partners
PhageEU is dedicated to representing the interests of the phage community and facilitating access to phage technology in the EU. With its headquarters and secretariat in Brussels, PhageEU is poised to shape the political and regulatory agenda in Europe, ensuring the full potential of phages is realized for the benefit of EU citizens, patients, and farmers.
The package includes:
Registration for the Global Phage Therapy Bridge is open until 31 December 2026.
As the event is intentionally kept small to encourage meaningful discussion and networking, the number of participants is limited. Registration may therefore close earlier if the maximum capacity is reached.
We recommend registering early to secure your place.
The registration fee does not include travel to and from Singapore, accommodation, airport transfers, visas or other travel documentation, travel insurance, or personal expenses incurred during the stay.
Participants are responsible for arranging their own travel and accommodation and for ensuring that they meet the applicable entry requirements for Singapore.
Registration cancellations must be submitted in writing by email.
Cancellations received on or before 30 November 2026 are eligible for a refund of 75% of the registration fee.
For cancellations received from 1 December 2026 onwards, no refund will be provided. No refunds will be issued for non attendance or no shows.
Participant substitutions are permitted free of charge. If a registered participant is unable to attend, the registration may be transferred to another person from the same organisation. Substitution requests must be submitted in writing before the event.
The organisers reserve the right to make reasonable changes to the programme, speakers, schedule, or other arrangements where necessary. Such changes do not normally entitle participants to a refund.
If the Global Phage Therapy Bridge is cancelled by the organisers, registration fees will be refunded. The organisers are not responsible for travel, accommodation, or other costs incurred by participants in connection with attending the event.
Any refunds will be made using the original payment method where possible.
Participants are responsible for ensuring that they meet the applicable requirements for entering Singapore.
Visa requirements depend on nationality and travel document. Participants should check the latest requirements directly with the Singapore Immigration & Checkpoints Authority (ICA) or the relevant Singapore embassy or consulate before travelling. Singapore's Ministry of Foreign Affairs also provides information on whether a visa is required.
At present, travellers to Singapore are generally required to submit the SG Arrival Card within three days before arrival, subject to the exemptions specified by the Singapore authorities. The SG Arrival Card is not a visa.
Registered participants who require confirmation of their participation or an invitation letter to support a visa application may contact the organisers. Please note that the issuance of an invitation letter does not guarantee that a visa will be granted.
As immigration requirements can change, participants should always verify the latest requirements with the Singapore authorities before travelling.
For questions regarding registration, invoicing, the programme, speaking opportunities, travel documentation, or other practical arrangements, please contact us.